← Open Payments lookup

MICHAEL KURTZ: Open Payments

NPI 1194814020 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,592 in 70 payments from 22 companies in 2025. Trend: 2023 $2,140 · 2024 $1,766 · 2025 $1,592

Food & beverage: $1,592
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$289
AstraZeneca Pharmaceuticals LP10$231
ABBVIE INC.9$222
Novo Nordisk Inc8$141
Antares Pharma, Inc.6$116
Bausch Health US, LLC5$107
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$106
Amgen Inc.3$52
Verity Pharmaceuticals Inc.1$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36

Products named: SPRAVATO, XYOSTED, Ozempic, APLENZIN, FARXIGA, QULIPTA, XIFAXAN, AIRSUPRA.

Industry payments across CA — which companies pay providers there.